- Home
- KTCC vs ANTX Comparison
KTCC vs ANTX Comparison
Compare KTCC & ANTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KTCC
- ANTX
- Stock Information
- Founded
- KTCC 1969
- ANTX 2017
- Country
- KTCC United States
- ANTX United States
- Employees
- KTCC N/A
- ANTX N/A
- Industry
- KTCC Electrical Products
- ANTX Biotechnology: Pharmaceutical Preparations
- Sector
- KTCC Technology
- ANTX Health Care
- Exchange
- KTCC Nasdaq
- ANTX Nasdaq
- Market Cap
- KTCC 31.2M
- ANTX 33.2M
- IPO Year
- KTCC N/A
- ANTX 2022
- Fundamental
- Price
- KTCC $2.93
- ANTX $1.07
- Analyst Decision
- KTCC
- ANTX Buy
- Analyst Count
- KTCC 0
- ANTX 2
- Target Price
- KTCC N/A
- ANTX $2.00
- AVG Volume (30 Days)
- KTCC 19.8K
- ANTX 71.9K
- Earning Date
- KTCC 08-12-2025
- ANTX 08-12-2025
- Dividend Yield
- KTCC N/A
- ANTX N/A
- EPS Growth
- KTCC N/A
- ANTX N/A
- EPS
- KTCC N/A
- ANTX N/A
- Revenue
- KTCC $483,941,000.00
- ANTX N/A
- Revenue This Year
- KTCC N/A
- ANTX N/A
- Revenue Next Year
- KTCC N/A
- ANTX N/A
- P/E Ratio
- KTCC N/A
- ANTX N/A
- Revenue Growth
- KTCC N/A
- ANTX N/A
- 52 Week Low
- KTCC $2.21
- ANTX $0.87
- 52 Week High
- KTCC $6.14
- ANTX $2.73
- Technical
- Relative Strength Index (RSI)
- KTCC 48.28
- ANTX 45.56
- Support Level
- KTCC $2.98
- ANTX $1.05
- Resistance Level
- KTCC $3.08
- ANTX $1.16
- Average True Range (ATR)
- KTCC 0.11
- ANTX 0.03
- MACD
- KTCC -0.01
- ANTX 0.00
- Stochastic Oscillator
- KTCC 5.26
- ANTX 18.87
About KTCC Key Tronic Corporation
Key Tronic Corp is an electronic manufacturing service provider. The company provides electronic manufacturing services to original equipment manufacturers in the United States and globally. Its primary services include integrated electronic and mechanical engineering, precision plastic molding, sheet metal fabrication, printed circuit board (PCB) and complete product assembly, component selection, sourcing and procurement, logistics, and new product testing and production. The firm derives a majority of its revenue from the United States.
About ANTX AN2 Therapeutics Inc.
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology.